Clinical Trials Directory

Trials / Unknown

UnknownNCT04993456

Calcitonin Level and New-onset of Post-Operative Atrial Fibrillation

Division of Cardiology, Department of Internal Medicne, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Tongji Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Post-operative atrial fibrillation (POAF) is one of the common complicaiton following cardiac surgery, occurring in approximately 20%-40% patients. Although POAF is associated with longer hospital stays, most POAF is short lived and resolves in the 2-4 days afer cardiac surgery. However, a recent meta-analysis showed significant increases in 1,5, and 10 year mortality in POAF patients (odds ratio:1.60, 2.60, 1.51;95% confidence intervals: 1.52 to 1.68, 2.00 to 3.38, 1.43 to 1.60;P \<0.0001), the combined adjusted risk of death (16 studies, n =84,295) was also significantly increased in patients with POAF (hazard ratio: 1.25;95% confidence interval: 1.2-1.3;P \< 0.0001). These data highlight the need to understand better the underlying mechanism of POAF. A latest research in Nature reported levels of circulating calcitonin (CT), which is the main risk factor for atrial fibrillation (AF). Global disruption of CT receptor signalling in mice causes atrial fibrosis and increases susceptibility to AF. Here we will explore the relationship between CT and POAF.

Conditions

Interventions

TypeNameDescription
PROCEDURECaridac surgeryCardiac surgery

Timeline

Start date
2021-06-15
Primary completion
2023-07-15
Completion
2024-07-15
First posted
2021-08-06
Last updated
2021-08-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04993456. Inclusion in this directory is not an endorsement.